基于对动脉样硬化症的诊断和治疗术策略的纳米输送系统的进步
Xi Yang1, Jian Hu2, Quanle Gao3
1Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Journal of drug targeting
|November 27, 2024
概括
纳米技术为早期动脉样硬化 (AS) 诊断和治疗提供了先进的解决方案. 本综述探讨了用于改进成像和向治疗的纳米输送系统,解决临床应用的挑战.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化 (AS) 是一种慢性炎症性疾病,需要早期诊断才能有效管理.
- 目前的诊断方法难以检测早期的AS病变,阻碍了及时的干预.
- 纳米传递系统为增强AS诊断和向治疗提供了一个有希望的方法.
研究的目的:
- 审查纳米传递系统与成像技术结合用于AS诊断的应用.
- 探索将成像技术与AS的theranostics策略集成的进步.
- 讨论纳米输送系统在AS临床转化中的挑战和未来前景.
主要方法:
- 关于在动脉样硬化诊断和神经神学中纳米输送系统的文献综述.
- 对AS的纳米医学集成成像技术的分析.
- 讨论临床翻译挑战,包括向,毒性和免疫反应.
主要成果:
- 纳米输送系统显示出改善斑块识别和AS药物输送的潜力.
- 结合各种成像方式与纳米异能学,为AS管理提供了协同效应的好处.
- 在纳米粒子向效率,细胞毒性和临床验证方面仍然存在重大挑战.
结论:
- 纳米输送系统在彻底改变动脉样硬化诊断和神经透学方面具有很大的前景.
- 克服针对性,安全性和疾病建模方面的挑战对于临床翻译至关重要.
- 未来的研究应该专注于开发针对AS的强大和临床可行的纳米异常药物策略.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis IV: Nursing Management
611
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611


